Literature DB >> 6453350

Reduced tumor growth after low-dose irradiation or immunization against blastic suppressor T cells.

A F Tilkin, N Schaaf-Lafontaine, A Van Acker, M Boccadoro, J Urbain.   

Abstract

Suppressor T cells have been shown to be much more radiosensitive than other lymphoïd cells, and we have tried to reduce tumor growth by low-dose irradiation. Syngeneic DBA/2 mice received whole-body irradiation (150 rads; 1 rad = 0.01 J/kg) 6 days after P815 tumor inoculation. Tumor growth is significantly reduced in mildly irradiated mice. We also attempted to reduce syngeneic tumor growth by raising immunity against suppressor T cells in two different systems. DBA/2 mice were immunized against splenic T cells collected after disappearance of cytotoxicity and then injected with P815 tumor cells. These mice develop a very high primary cytotoxicity against P815 cells. C57BL/6 mice were immunized against blastic suppressor T cells, before injection of T2 tumor cells. Some of these mice reject the tumor and other develop smaller tumors than control mice. These results could be explained by the induction of antiidiotypic activity directed against the immunological receptors of suppressor T lymphocytes, because immunization with blastic suppressor T cells from mice bearing the T2 tumor does not modify the growth of another tumor, T10.

Entities:  

Mesh:

Year:  1981        PMID: 6453350      PMCID: PMC319224          DOI: 10.1073/pnas.78.3.1809

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Cellular interaction between cytotoxic and suppressor T cells against syngeneic tumors in the mouse.

Authors:  S Fujimoto; T Matsuzawa; K Nakagawa; T Tada
Journal:  Cell Immunol       Date:  1978-07       Impact factor: 4.868

2.  Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.

Authors:  K T Brunner; J Mauel; J C Cerottini; B Chapuis
Journal:  Immunology       Date:  1968-02       Impact factor: 7.397

3.  Enhanced syngeneic tumor destruction by in vivo inhibition of suppressor T cells using anti-I-J alloantiserum.

Authors:  L L Perry; B Benacerraf; R T McCluskey; M I Greene
Journal:  Am J Pathol       Date:  1978-08       Impact factor: 4.307

4.  Idiotypic regulation of the immune system by the induction of antibodies against anti-idiotypic antibodies.

Authors:  J Urbain; M Wikler; J D Franssen; C Collignon
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

5.  Suppression of tumor rejection by autologous anti-idiotypic immunity.

Authors:  P M Flood; M L Kripke; D A Rowley; H Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

6.  Idiotypic-anti-idiotypic regulation of antibody synthesis in rabbits.

Authors:  P A Cazenave
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

7.  Characterization of suppressor cells in mice bearing syngeneic mastocytoma.

Authors:  F Takei; J G Levy; D G Kilburn
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

8.  Separation of lymphoid cells with a suppressor effect on the activity of cytotoxic cells in vitro during the growth of a syngeneic mouse tumour.

Authors:  N Schaaf-Lafontaine
Journal:  Int J Cancer       Date:  1978-03-15       Impact factor: 7.396

9.  Antiinflammatory effects of murine malignant cells.

Authors:  R M Fauve; B Hevin; H Jacob; J A Gaillard; F Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

10.  Induction of specific immune unresponsiveness with purified mixed leukocyte culture-activated T lymphoblasts as autoimmunogen. II. An analysis of the effects measured at the cellular and serological levels.

Authors:  M Aguet; L C Andersson; R Andersson; E Wight; H Binz; H Wigzell
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

View more
  17 in total

Review 1.  Possible role of anti-idiotypic antibodies in the induction of tumor immunity.

Authors:  R C Kennedy; E M Zhou; R E Lanford; T C Chanh; C A Bona
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

Review 2.  Anti-idiotypic antibodies and the induction of specific tumor immunity.

Authors:  G T Nepom; K E Hellström
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  The effects of cyclophosphamide and irradiation singly and in combination upon SaI growth in A/J mice.

Authors:  R E Anderson; W L Williams; S Tokuda
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

Review 4.  Suppressor mechanisms in tumor immunity.

Authors:  G T Nepom; I Hellström; K E Hellström
Journal:  Experientia       Date:  1983-03-15

Review 5.  Regulation of the immune response to antigens on the malignant cell surface.

Authors:  J A Drebin; L L Perry; R Carter; M I Greene
Journal:  Springer Semin Immunopathol       Date:  1982

6.  Radiation-induced augmentation of the response of A/J mice to SaI tumor cells.

Authors:  R E Anderson; S Tokuda; W L Williams; N L Warner
Journal:  Am J Pathol       Date:  1982-07       Impact factor: 4.307

7.  Studies on chemically induced tumors in rats: I. Heterogeneity of tumor cells and establishment of syngeneic, tumor-specific cytotoxic T cell clones.

Authors:  H Binz; M Fenner; H Wigzell
Journal:  Experientia       Date:  1983-01-15

8.  Induction of immunity to a human tumor marker by in vivo administration of anti-idiotypic antibodies in mice.

Authors:  G T Nepom; K A Nelson; S L Holbeck; I Hellström; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

9.  Radiobiological basis for cancer therapy by total or half-body irradiation.

Authors:  Kiyohiko Sakamoto
Journal:  Nonlinearity Biol Toxicol Med       Date:  2004-10

10.  Regulation of immune responses aginst the syngeneic ADJ-PC-5 plasmacytoma in BALB-c mice. III. Induction of specific T suppressor cells to the BALB/c plasmacytoma ADJ-PC-5 during early stages of tumorigenesis.

Authors:  H D Haubeck; E Kölsch
Journal:  Immunology       Date:  1982-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.